David Anstice
President presso Banyu Pharmaceutical Co. Ltd.
Profilo
David Westbrook Anstice is currently the Vice Chairman at United States Studies Centre.
He also holds current positions as an Independent Director at Alkermes, Inc., President & Director at Banyu Pharmaceutical Co. Ltd., Director at The University of Sydney USA Foundation, Director at Us Foundation of The University of The Valley of Guatemala, Non-Executive Director at NeuClone Pty Ltd., and Director at Neuclone Pharmaceuticals Pty Ltd.
In the past, Mr. Anstice served as the Chairman at National Pharmaceutical Council.
He was also an Independent Non-Executive Director at CSL Ltd.
from 2012 to 2018.
Additionally, he worked as a Director at Biotechnology Innovation Organization from 1996 to 2005, and as a Director at Alkermes Plc from 2008 to 2011.
Prior to that, he held the position of Executive Vice President at Merck & Co., Inc. from 2006 to 2008.
Mr. Anstice completed his undergraduate degree at The University of Sydney in 1970.
Posizioni attive di David Anstice
| Società | Posizione | Inizio |
|---|---|---|
Banyu Pharmaceutical Co. Ltd.
 Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | President | 01/10/2007 |
| The University of Sydney USA Foundation | Director/Board Member | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director/Board Member | 16/09/2011 |
| Us Foundation of The University of The Valley of Guatemala | Director/Board Member | - |
NeuClone Pty Ltd.
 NeuClone Pty Ltd. BiotechnologyHealth Technology NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia. | Director/Board Member | - |
| United States Studies Centre | Director/Board Member | - |
Neuclone Pharmaceuticals Pty Ltd.
 Neuclone Pharmaceuticals Pty Ltd. BiotechnologyHealth Technology Neuclone Pharmaceuticals Pty Ltd. manufactures biological products. The private company is based in Sydney, Australia. | Director/Board Member | - |
Precedenti posizioni note di David Anstice
| Società | Posizione | Fine |
|---|---|---|
| ALKERMES PLC | Director/Board Member | 07/07/2022 |
| CSL LIMITED | Director/Board Member | 17/10/2018 |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | - |
Formazione di David Anstice
| The University of Sydney | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CSL LIMITED | Health Technology |
| ALKERMES PLC | Health Technology |
| Aziende private | 8 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Banyu Pharmaceutical Co. Ltd.
Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan. | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
| The University of Sydney USA Foundation | |
| Us Foundation of The University of The Valley of Guatemala | |
NeuClone Pty Ltd.
NeuClone Pty Ltd. BiotechnologyHealth Technology NeuClone Pty Ltd. develops biological products. It provides NeuMAX, a platform technology for manufacturing protein therapeutics. The firm offers cell lines engineering services for manufacturing biological drugs. The company was founded by Noelle Sunstrom in 2007 and is headquartered in Sydney, Australia. | Health Technology |
Neuclone Pharmaceuticals Pty Ltd.
Neuclone Pharmaceuticals Pty Ltd. BiotechnologyHealth Technology Neuclone Pharmaceuticals Pty Ltd. manufactures biological products. The private company is based in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- David Anstice
